Jpmorgan Chase & CO Zimmer Biomet Holdings, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,743,434 shares of ZBH stock, worth $300 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,743,434
Previous 3,562,920
23.0%
Holding current value
$300 Million
Previous $387 Million
23.42%
% of portfolio
0.02%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding ZBH
# of Institutions
1,080Shares Held
179MCall Options Held
301KPut Options Held
1M-
Vanguard Group Inc Valley Forge, PA23.3MShares$2.54 Billion0.05% of portfolio
-
Dodge & Cox San Francisco, CA17.1MShares$1.87 Billion1.12% of portfolio
-
Black Rock Inc. New York, NY16.8MShares$1.84 Billion0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD14.6MShares$1.59 Billion0.18% of portfolio
-
State Street Corp Boston, MA9.08MShares$993 Million0.04% of portfolio
About ZIMMER BIOMET HOLDINGS, INC.
- Ticker ZBH
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 209,820,000
- Market Cap $22.9B
- Description
- Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...